Clinical Trial Update: Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing NN1250 with insulin glargine in adults with Type 2 diabetes; the study is completed and results were posted in December 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• NN1250

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-12-28